Moreland Mary K's Form 4 filing
Abbott LaboratoriesABT · filed Mar 4, 2024
- Accession no.
- 0001415889-24-006410
- Filed
- Mar 4, 2024
- Trade date
- Feb 29-Mar 1, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $80.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Moreland Mary KCIK 0001783147 | Officer (EXECUTIVE VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 29, 2024 | Common shares without par value | FTax withholdingDisposed | −5,862 | $120.05 | −$703,733.1 | 91,936 | Direct | |
| Mar 1, 2024 | Common shares without par value | SSaleDisposed | −676 | $118.50 | −$80,106 | 91,260 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.